In vitro use of autologous dendritic cells improves detection of T cell responses to hepatitis B virus (HBV) antigens

Journal of Medical Virology

Volumn 81, Issue 2, 2009, Pages 332-339

  Carotenuto, Patrizia ^a   Artsen, Andrè ^a   Niesters, Hubert G ^a   Osterhaus, Albert D ^a   Pontesilli, Oscar ^a,b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Maasstad Hospital Rotterdam   (Netherlands)

Author keywords

HBcAg; HBsAg; Interferon ; Lymphoproliferation

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; LAMIVUDINE; MACROGOL; PEGINTERFERON ALPHA; PEGINTERFERON ALPHA2B; RECOMBINANT HEPATITIS B VACCINE; ANTIVIRUS AGENT; HEPATITIS B ANTIGEN; HEPATITIS B CORE ANTIGEN;

ANTIVIRAL THERAPY; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; DENDRITIC CELL; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MONOTHERAPY; STIMULATION; T LYMPHOCYTE; VIRUS REPLICATION; ADULT; GENETICS; IMMUNOLOGY; LONGITUDINAL STUDY;

ADULT; ANTIVIRAL AGENTS; DENDRITIC CELLS; HEPATITIS B ANTIGENS; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LONGITUDINAL STUDIES; T-LYMPHOCYTES;

HEPATITIS B VIRUS;

EID: 61749093304     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21333     Document Type: Article

References (33)

1. ACTG Laboratory Technologist Committee. 2000. Lymphocyte proliferation assay (LPA). aactg.s-3.com/pub/download/labmanual/29-ALM-Lymphocyte- Proliferation-Assay.pdf.
2. Altman JD, Moss PAH, Goulder PJR, Barouch DH, McHeyzer-Williams MG, Bell JI, McMichael AJ, Davis MM. 1996. Phenotypic analysis of antigen-specific T lymphocytes. Science 274:94-96.
3. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, Palucka K. 2000. Immunobiology of dendritic cells. Annu Rev Immunol 18:767-811.
4. Bertoletti A, Maini M, Williams R. 2003. Role of hepatitis B virus specific cytotoxic T cells in liver damage and viral control. Antiviral Res 60:61-66.
5. Böcher WO, Herzog-Hauff S, Schlaak J, Meyer zum Büschenfelde KH, Löhr HF. 1999. Kinetics of Hepatitis B surface antigen-specific immune responses in acute and chronic hepatitis B or after HBs vaccination: stimulation of the in vitro antibody response by interferon gamma. Hepatology 29:238-244.
6. Boni C, Bertoletti A, Penna A, Cavalli A, Pilli M, Urbani S, Scognamiglio P, Boehme R, Panebianco R, Fiaccadori F, Ferrari C. 1998. Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B. J Clin Invest 102:968-975.
7. Carotenuto P, van Riel D, Artsen A, Bruijns S, Uytdehaag FG, Laman JD, van Nunen AB, Zondervan PE, de Man RA, Osterhaus AD, Pontesilli O. 2005. Antiviral treatment with alpha-interferon upregulates CD14 on liver macrophages and its soluble form in patients with chronic hepatitis B. Antimicrob Agents Chemother 49:590-599.
8. Chisari FV, Ferrari C. 1995. Hepatitis B virus immunopathogenesis. Annu Rev Immunol 13:29-60.
9. Ferrari C, Penna A, Bertoletti A, Valli A, Antoni AD, Giuberti T, Cavalli A, Petit MA, Fiaccadori F. 1990. Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection. J. Immunol 145:3442-3449.
10. Ferrari C, Missale G, Boni C, Urbani S. 2003. Immunopathogenesis of hepatitis B. J Hepatol 39:S36-S42.
11. Gehring AJ, Sun D, Kennedy PTF, Nolte-'t Hoen E, Lim SG, Wasser S, Selden C, Maini MK, Davis DM, Nassal M, Bertoletti A. 2007. The level of viral antigen presented by hepatocytes influences CD8 T-cell function. J Virol 81:2940-2949.
12. Guermonprez P, Valladeau J, Zitvogel L, Thery C, Amigorena S. 2002. Antigen presentation and T cell stimulation by dendritic cells. Annu Rev Immunol 20:621-667.
13. Huang X-L, Fan Z, Colleton BA, Buchli R, Li H, Hildebrand WH, Rinaldo CR Jr. 2005. Processing and presentation of exogenous HLA class I peptides by dendritic cells from human immunodeficiency virus type 1-infected persons. J Virol 79:3052-3062.
14. Janssen HL, van Zonneveld M, Senturk H, Zeuzem S, Akarca US, Cakaloglu Y, Simon C, So TM, Gerken G, de Man RA, Niesters HG, Zondervan P, Hansen B, Schalm SW. 2005. Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial. Lancet 365:123-129.
15. Jung MC, Pape GR. 2002. Immunology of hepatitis B infection. Lancet Infect Dis 2:43-50.
16. Leroux-Roels G, Van Ecke E, Michielsen W, Voet P, Hauser P, Pêtre J. 1994. Correlation between in vivo humoral and in vitro cellular immune responses following immunization with hepatitis B surface (HBsAg) vaccines. Vaccine 12:812-817.
17. + T cells can be detected and characterized at the single cell level: limited usefulness of dendritic cells as signal enhancers. J Immunol Meth 330:1-11.
18. + T cells by a novel method using monocyte-derived HCMV-infected immature dendritic cells. Eur J Immunol 35:1795-1804.
19. Michel M, Mancini-Bourgine M. 2005. Therapeutic vaccination against chronic hepatitis B virus infection. J Clin Virol 34:S108-S114.
20. Nestle FO, Banchereau J, Hart D. 2001. Dendritic cell: on the move from bench to bedside. Nat Med 7:761-765.
21. Niesters HG, Krajden M, Cork L, de Medina M, Hill M, Fries E, Osterhaus AD. 2000. A multicenter study evaluation of the Digene hybrid capture II signal amplification technique for detection of hepatitis B virus DNA in serum samples and testing of EUROHEP standards. J Clin Microbiol 38:2150-2155.
22. Oldstone MB. 1998. Viral persistence: mechanisms and consequences. Curr Opin Microbiol 1:436-441.
23. Penna A, Artini M, Cavalli A, Levrero M, Bertoletti A, Pilli M, Chisari FV, Rehermann B, Del Prete G, Fiaccadori F, Ferrari C. 1996. Long-lasting memory T cell responses following self-limited acute hepatitis B. J Clin Invest 98:1185-1194.
24. Pontesilli O, van Nunen AB, van Riel D, Carotenuto P, Niesters HG, Uytdehaag FG, de Man RA, Osterhaus AD. 2004. Hepatitis B virus-specific T cell response in chronic hepatitis B patients treated with lamivudine and interferon-α. Liver Int 24:308-315.
25. Romani N, Reider D, Heuer M, Ebner S, Kampgen E, Eibl B, Niederwieser D, Schuler G. 1996. Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J Immunol Methods 196:137-151.
26. Schadendorf D, Nestle FO. 2001. Autologous dendritic cells for treatment of advanced cancer: an update. Recent Results Cancer Res 158:236-248.
27. Shen Z, Reznikoff G, Dranoff G, Rock KL. 1997. Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J Immunol 158:2723-2730.
28. Steinman RM. 1991. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 9:271-296.
29. Steinman RM, Cohn ZA. 1973. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J Exp Med 137:1142-1162.
30. + T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. J Virol 77:68-76.
31. + T cells specific for structural and nonstructural Hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy. J Virol 78:5707-5719.
32. Whiteside TL. 2000. Monitoring of antigen-specific cytolytic T lymphocytes in cancer patients receiving immunotherapy. Clin Diagn Lab Immunol 7:327-332.
33. + dendritic cells. Proc Natl Acad Sci USA 93:2588-2592.